Early safety check: does new heart pill mix well with old standbys?
NCT ID NCT07431866
Summary
This early-stage study aims to understand if a new investigational drug for heart failure (MK-2828) changes how the body processes two common medications: a cholesterol drug (rosuvastatin) and a water pill (furosemide). Researchers will give these drugs to 39 healthy participants and take many blood samples to measure drug levels. The main goal is to check for any unexpected interactions and assess safety before testing in people with heart disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit Inc ( Site 0001)
RECRUITINGDaytona Beach, Florida, 32117, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.